New oral drug could stop blood condition from turning into cancer
NCT ID NCT07435636
First seen Mar 05, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tests a low-dose oral drug (decitabine with tetrahydrouridine) in 80 people aged 60-85 with a high-risk blood condition called CCUS, which often leads to blood cancer. The drug aims to reduce harmful blood cell mutations and restore normal blood production without the harsh side effects of standard cancer treatments. Participants will take the drug or a placebo for 24 weeks to see if it can safely prevent disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Canberra Health Services
Canberra, Australian Capital Territory, 2605, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prince of Wales Hospital
Randwick, New South Wales, 2031, Australia
Contact Phone: •••-•••-••••
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.